News

A wearable robot that detects small arm motions and supports the shoulder helped ALS patients lift and carry things, a study ...
Courtesy of Tianiin University. Chinese scientists have stepped up research in brain-computer interface (BCI) technology ...
Neurizon starts manufacturing initial registration batch of NUZ-001 tablets to potentially treat ALS and related ...
Tommy and Vickie Smith have faced more than their share of health challenges. Tommy has been living with amyotrophic lateral ...
Leonard Lopate, a longtime public radio host at WNYC in New York, has died. His brother, Phillip Lopate, told the New York ...
Measuring the electrical activity of muscles in the neck in ALS may be easier for some patients than using the tongue for ...
Eric Brunner thought his coordination issues were from exhaustion. It turns out, they were early signs of ALS. Now he's ...
ProMIS Neurosciences Inc. advanced stock charts by Barron's. View PMN historical stock data and compare to other stocks, and exchanges.
A patient with amyotrophic lateral sclerosis (ALS) has become the first person in the world to control an iPad entirely by thought, according to neurotech company Synchron.
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company developing novel ...
The company is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study, it ...
Detailed price information for Pharmadrug Inc (PHRX-CN) from The Globe and Mail including charting and trades.